Abstract
Various authors have observed and reported an association between perioperative blood transfusions and disease-free survival time in patients with malignant tumors. Interest in this relationship began from the observation that perioperative transfusions improved graft survival in patients undergoing kidney transplantation [1]. Based on these clinical data, in 1981 Gantt stated his belief that blood transfusions in patients with malignant tumors would give the tumor “a better chance to survive” [2]. Since that time clinical investigations have been carried out to confirm the relationship between perioperative blood transfusions and a worse prognosis. Most of the data concern colerectal cancer [3–7], lung cancer [8,9], breast cancer [7,10–12], soft tissue sarcomas [13], and head and neck cancer [14].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fischer E, Lenhard V, Sieffert P, et al. Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol 3:187–194, 1980.
Gantt CL. Red blood cells for cancer patients (letter). Lancet 2:363, 1981.
Burrows L, Tartter P. Effect of blood transfusion on clonic malignancy recurrence rate. Lancet 2:662, 1982.
Blumberg N, Heal JM, Murphy P, et al. Association between transfusion of whole blood and recurrence of cancer. Br Med J 293:530–533, 1986.
Foster RS Jr., Costanza MC, Foster JC, et al. Adverse relationship between blood transfusion and survival after colectomy for colon cancer. Cancer 55:1195–1201, 1985.
Corman J, Arnoux R, Peloquin A, et al. Blood transfusion and survival after colectomy for colorectal cancer. Can J Surg 29:325–329, 1986.
Voogt PJ, Van de Velde CJH, Brand A, et al. Perioperative blood transfusion and cancer prognosis: different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer 59:836–843, 1987.
Tartter PI, Burrows I, Kirshner P. Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset No) non-oat cell lung cancer. J Thorac Cardiovasc Surg 88:659–662, 1984.
Hyman NH, Foster RS, De Meules JE, et al. Blood transfusions and survival after lung cancer resection. Am J Surg 149:502–507, 1985.
Nowak M, Ponsky J. Blood transfusion and disease-free survival in carcinoma of the breast. J Surg Oncol 27:124–130, 1984.
Foster RS Jr., Foster JC, Costanza MC. Blood transfusions and survival after surgery for breast cancer. Arch Surg 119:1138–1140, 1984.
Tartter PI, Burrows L, Papatestas AE, et al. Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 97:225–229, 1985.
Rosenberg SA, Seipp CA, White DE, et al. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft tissue sarcomas of the extremities. J Clin Oncol 3:698–709, 1985.
Johnson JT, Taylor FH, Thearle PB. Blood transfusion and outcome in stage III head and neck carcinoma. Ann Otolaryngol Head Neck Surg 113:307–310, 1987.
Chesi R, Cazzola A, Bacci G, et al. Effect of perioperative transfusions on survival in osteosarcoma treated by multimodal therapy. Cancer 64:1727–1737, 1989.
Waymack JP, Chance WT. Effect of blood transfusions on immune function: IV. Effect on tumor growth. J Surg Oncol 39:159–164, 1988.
Waymack JP, Rapien J, Garnett D, et al. Effect of transfusion on immune function in a traumatized animal model. Arch Surg 121:50–54, 1986.
Waymack JP, Gallon L, Barcelli U, Alexander JW. Effect of blood transfusions on immune function. Alterations in macrophage arachidonic acid metabolism. Arcn Surg 122:56–60, 1987.
Waymack JP, Gallon L, Barcelli U, Alexander JW. Effect of transfusion on macrophage function in a burned animal model. Curr Surg 43:305–307, 1986.
Smith MD, Williams JD, Coles GA, et al. The effect of blood transfusion on T-suppressor cells in renal dialysis patients. Transplant Proc 13:181–183, 1981.
Kessler CM, Schulof RS, Goldstein AL, et al. Abnormal T-lymphocyte subpopulations associated with transfusions of blood-derived products. Lancet 1:991–992, 1983.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chesi, R., Borghi, B., Lari, S. (1993). Perioperative blood transfusions and survival in osteosarcoma. In: Humphrey, G.B., Koops, H.S., Molenaar, W.M., Postma, A. (eds) Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Cancer Treatment and Research, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3518-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3518-8_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6561-7
Online ISBN: 978-1-4615-3518-8
eBook Packages: Springer Book Archive